Institut Bergonié

This study looked at whether adding a simple blood test (liquid biopsy) to the usual tissue biopsy can help find more EGFR gene mutations in people with advanced non-small cell lung cancer. Over 500 patients were tested using both methods. The goal was to see if the combination a…

This study examined tumor samples from 3,820 people with advanced solid cancers to find how many had NTRK gene fusions. Researchers used genetic testing to identify these rare changes. The goal was to understand how common these fusions are, not to test a new treatment.

This study created a new statistical method to figure out the right number of participants for clinical trials when patients have different risks or respond differently to treatment. Researchers analyzed data from 500 people to improve trial design. The goal is to make future tri…

This study brought together experts to decide what health outcomes matter most when testing cancer treatments in older adults. Instead of focusing only on tumor shrinkage, they highlighted areas like independence, memory, mood, and nutrition. The goal is to make future clinical t…

This study looked at erectile dysfunction in 12 men treated for early-stage rectal cancer. The goal was to objectively measure sexual side effects after surgery using a special device called RIGISCAN® PLUS. The study did not test a new treatment, but aimed to better understand ho…

This study examined how social, economic, and health factors influence cancer treatment and survival in people aged 65 and older. Researchers analyzed data from 450 elderly cancer patients in France to see who received treatment and who survived one year after diagnosis. The goal…